Post transplant lymphoproliferative disorder: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "MARIA MARIA")
Line 1: Line 1:
{{Infobox_Disease |
MARIA MARIA
  Name          = {{PAGENAME}} |
  Image          = |
  Caption        = |
  DiseasesDB    = 34154 |
  ICD10          = |
  ICD9          = |
  ICDO          = M9970/1  |
  OMIM          = |
  MedlinePlus    = |
  MeshID        = |
}}
{{Post transplant lymphoproliferative disorder}}
'''For patient information on this page, click [[Post transplant lymphoproliferative disorder (patient information)|here]]'''
 
 
{{CMG}}
 
{{SK}} PTLD
 
==[[Post transplant lymphoproliferative disorder overview|Overview]]==
 
==[[Post transplant lymphoproliferative disorder historical perspective|Historical Perspective]]==
 
==[[Post transplant lymphoproliferative disorder pathophysiology|Pathophysiology]]==
 
==[[Post transplant lymphoproliferative disorder causes|Causes]]==
 
==[[Post transplant lymphoproliferative disorder differential diagnosis|Differentiating Post transplant lymphoproliferative disorder from other Diseases]]==
 
==[[Post transplant lymphoproliferative disorder epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Post transplant lymphoproliferative disorder natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
 
[[Post transplant lymphoproliferative disorder history and symptoms|History and Symptoms]] | [[Post transplant lymphoproliferative disorder physical examination|Physical Examination]] | [[Post transplant lymphoproliferative disorder laboratory findings|Laboratory Findings]] | [[Post transplant lymphoproliferative disorder other imaging findings|Other Imaging Findings]] | [[Post transplant lymphoproliferative disorder other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
 
[[Post transplant lymphoproliferative disorder medical therapy|Medical Therapy]] | [[Post transplant lymphoproliferative disorder surgery|Surgery]] | [[Post transplant lymphoproliferative disorder cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Post transplant lymphoproliferative disorder future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
[[Post transplant lymphoproliferative disorder case study one|Case #1]]
 
==Related chapters==
*[[Epstein Barr virus]]
 
 
{{Organ transplantation}}
{{Hematological malignancy histology}}
 
<!--Categories-->
[[Category:Transplantation medicine]]
[[Category:Oncology]]
[[Category:Hematology]]
 
<!--Other languages-->
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 20:21, 23 May 2016

MARIA MARIA